Refining method for vancomycin hydrochloride

A vancomycin hydrochloride and refining method technology, applied in the direction of peptides, etc., can solve the problems of difficult filtration, fine crystals, and inability to recycle, and achieve the effect of simple operation and high yield

Inactive Publication Date: 2014-09-17
FUJIAN BOMEI BIOLOGICAL TECH CO LTD
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this refining process adopts the crystallization method of adding nearly 2 times the amount (V / V) of ethanol. This crystallization method has several defects: 1) It adopts the crystallization method of adding an organic solvent that is miscible with water, which is limited by the crystallization process and cannot be heated. and pH2.5-3.0, the obtained crystals are fine and sticky, difficult to filter
2) The organic solvent in the mother liquor needs to be recovered by heating, resulting in the total 10-20% of vancomycin hydrochloride in the mother liquor being degraded by heat and unable to be recycled
3) The incomplete recovery of organic solvents in the mother liquor and the thermal degradation products of vancomycin hydrochloride put pressure on environmental protection treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Refining method for vancomycin hydrochloride
  • Refining method for vancomycin hydrochloride
  • Refining method for vancomycin hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1: Preparation of vancomycin hydrochloride solution

[0028]3.62 liters of vancomycin hydrochloride extract with a concentration of 87 g / L and a purity of 82% was passed through a chromatographic column equipped with 4 liters of PS / DVB reverse chromatographic filler. Then use a gradient top wash with 5% n-butanol aqueous solution, and the concentration of n-butanol aqueous solution rises to 10% at the end of the top wash. The eluted fractions were collected in sections with an automatic collector, and the purity of the fractions was detected by HPLC. Fractions with a purity of more than 90% were combined and concentrated by nanofiltration to obtain 3.45 liters of vancomycin hydrochloride solution. Concentration: 68.98 g / L, yield: 85.0%, purity: 91.82%, see figure 2 .

Embodiment 2

[0029] Embodiment 2: Preparation of vancomycin

[0030] 3 liters of the vancomycin hydrochloride solution that example 1 makes is put in the cold water bath of 15 ℃. Add 30 grams of solid ammonium chloride under stirring, stir well to dissolve it completely, adjust the pH to 8.08 with 4N ammonia water under stirring, stir for 3 hours, during which a large amount of solids precipitate, and let it stand overnight. The solid was collected by suction filtration. The obtained solid was dried under high vacuum at 30°C for 4 hours, then pulverized, and then dried under high vacuum at 30°C for 20 hours. Get 197.4 grams of vancomycin solid. Potency: 868μg / mg, yield: 90.18%, purity: 95.68%, see image 3 .

Embodiment 3

[0031] Embodiment 3: Preparation of vancomycin hydrochloride

[0032] Suspend 180 g of the vancomycin solid obtained in Example 2 in 8 liters of purified water, cool to 5°C, adjust the pH to 2.8 with 4M hydrochloric acid under stirring, and fully dissolve it. The solution was placed in a nanofiltration system and concentrated to a volume of 4 liters. Add 4 liters of purified water and continue to concentrate to a volume of 4 liters. This washing operation was repeated 5 times. Finally the solution was concentrated to a volume of 1.3 liters.

[0033] Add 10 grams of activated carbon to the above concentrate, stir at room temperature for 30 minutes, filter, and then filter the filtrate through a 0.22 μm membrane, put it in a plate, put it in a freeze dryer, and freeze it at -45°C for 4 hours. Turn on the vacuum to below 15Pa for sublimation, and raise the temperature to -10°C, and keep the vacuum at this temperature for 10 hours. Then continue to raise the temperature to 0°C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to view more

Abstract

The invention discloses a refining method for vancomycin hydrochloride. In the method, a vancomycin hydrochloride solution of which the purity is over 90 percent is refined into vancomycin hydrochloride of which the purity is over 95 percent; and in a refining process, solid-liquid separation is realized without using any organic solvent, and the yield is over 80 percent. Vancomycin in a mother solution obtained through solid-liquid separation can be returned to a previous separating process for recycling. The refining method is easy and convenient for operating, has high yield, and is a feasible industrial refining process.

Description

technical field [0001] The invention belongs to the technical field of purification, in particular to a method for refining vancomycin hydrochloride. Background technique [0002] Vancomycin hydrochloride was developed by Eli Lilly and Company in 1958. It is a glycopeptide antibiotic produced by the fermentation of Actinomycetes genus A. orientalis under suitable conditions. Because vancomycin hydrochloride has no cross-resistance with other antibiotics, and has a strong killing effect on drug-resistant Staphylococcus aureus, it has always been concerned by clinicians. However, it was reported in the literature in the past that vancomycin has severe renal and ototoxicity, so it has not been widely used in clinical practice. [0003] In recent years, due to the extensive use of antibiotics, the number of clinical cases of methicillin-resistant Staphylococcus aureus (MASA) infection is increasing. This infection is fatal to postoperative patients and patients with low immunit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K9/00C07K1/14
Inventor 赵宁方整国许锡南方如穗罗福东
Owner FUJIAN BOMEI BIOLOGICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap